Sheila  Weinmann  to  Breast Neoplasms
                            
                            
                                This is a "connection" page, showing publications  Sheila  Weinmann  has written about  Breast Neoplasms.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.729
         
        
        
     
 
    
        
        - 
            Cellular senescence predicts breast cancer risk from benign breast disease biopsy images. Breast Cancer Res. 2025 Mar 11; 27(1):37.
            
            
                Score: 0.138
             
- 
            Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005; (35):33-8.
            
            
                Score: 0.137
             
- 
            Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care. 2003 Nov; 9(11):745-55.
            
            
                Score: 0.126
             
- 
            Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort. Breast Cancer Res. 2023 05 03; 25(1):50.
            
            
                Score: 0.122
             
- 
            Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. Lancet Oncol. 2022 11; 23(11):1451-1464.
            
            
                Score: 0.117
             
- 
            A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):93-102.
            
            
                Score: 0.116
             
- 
            Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. JNCI Cancer Spectr. 2022 May 02; 6(3).
            
            
                Score: 0.113
             
- 
            Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. Breast Cancer Res Treat. 2022 May; 193(1):203-216.
            
            
                Score: 0.112
             
- 
            Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun. 2021 11 03; 12(1):6341.
            
            
                Score: 0.110
             
- 
            Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer. Breast Cancer Res. 2021 01 30; 23(1):15.
            
            
                Score: 0.104
             
- 
            Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mol Carcinog. 2020 07; 59(7):701-712.
            
            
                Score: 0.098
             
- 
            Response to Comment on "Bariatric Surgery is Associated With Reduced Risk of Breast Cancer in Both Premenopausal and Postmenopausal Women". Ann Surg. 2020 02; 271(2):e19-e20.
            
            
                Score: 0.097
             
- 
            RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery. BMC Med Genomics. 2019 12 19; 12(1):195.
            
            
                Score: 0.096
             
- 
            A miRNA Expression Signature in Breast Tumor Tissue Is Associated with Risk of Distant Metastasis. Cancer Res. 2019 04 01; 79(7):1705-1713.
            
            
                Score: 0.091
             
- 
            HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics. 2012; 15(1):1-10.
            
            
                Score: 0.053
             
- 
            Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection? J Natl Cancer Inst Monogr. 2005; (35):39-46.
            
            
                Score: 0.034
             
- 
            Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004 Oct 20; 96(20):1518-27.
            
            
                Score: 0.034
             
- 
            Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs. Genet Med. 2003 Nov-Dec; 5(6):444-50.
            
            
                Score: 0.031